These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16188124)

  • 1. [Antisense hypoxia inducible factor-1alpha and B7-1 combination gene therapy for mouse lymphoma].
    Sun XY; Meng FQ; Jiang HC; Qiao HQ; Li W
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):404-7. PubMed ID: 16188124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Gene Ther; 2001 Apr; 8(8):638-45. PubMed ID: 11320410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha.
    Sun X; Kanwar JR; Leung E; Vale M; Krissansen GW
    Gene Ther; 2003 Dec; 10(25):2081-9. PubMed ID: 14595381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
    Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
    Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense HIF-1alpha prevents acquired tumor resistance to angiostatin gene therapy.
    Sun X; Vale M; Jiang X; Gupta R; Krissansen GW
    Cancer Gene Ther; 2010 Aug; 17(8):532-40. PubMed ID: 20348876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene transfer of von Hippel-Lindau inhibits the growth of transplanted solid tumors].
    Sun XY; Wang JL; Tang B; Liu FJ; Qiao HQ; Jiang HC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):241-4. PubMed ID: 16167238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of interfering RNA targeting HIF-1alpha and VEGF on retinal neovascularization in the mouse].
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):921-8. PubMed ID: 19176122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549.
    Zhang W; Zhang H; Xing L
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):448-50. PubMed ID: 17120745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1alpha degradation.
    Kim WJ; Cho H; Lee SW; Kim YJ; Kim KW
    Int J Oncol; 2005 Apr; 26(4):1049-52. PubMed ID: 15754001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of HIF-1alpha antisense oligonucleotide on implanted human gastric cancer in nude mice].
    He T; Li YH; Wang DD; Zhang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):49-52, 76. PubMed ID: 20369469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined gene therapy with hypoxia-inducible factor-1α and heme oxygenase-1 for therapeutic angiogenesis.
    Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Kim GH; Kim HA; Lee M; Kim BS
    Tissue Eng Part A; 2011 Apr; 17(7-8):915-26. PubMed ID: 20979535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
    Chen JX; Stinnett A
    Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.
    Kanwar JR; Shen WP; Kanwar RK; Berg RW; Krissansen GW
    J Natl Cancer Inst; 2001 Oct; 93(20):1541-52. PubMed ID: 11604477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of hypoxia inducible factor-1alpha on cervical cancer cell line HeLa in vitro].
    Cheng YX; Pu DM; Liu R; Li T; Yin L; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):551-4. PubMed ID: 17983496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver.
    Sun X; Krissansen GW; Fung PW; Xu S; Shi J; Man K; Fan ST; Xu R
    Int J Cancer; 2005 Feb; 113(4):670-7. PubMed ID: 15472906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis.
    Wang CH; Yao H; Chen LN; Jia JF; Wang L; Dai JY; Zheng ZH; Chen ZN; Zhu P
    Arthritis Rheum; 2012 Jun; 64(6):1818-27. PubMed ID: 22170561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.